首页> 外文期刊>Advances in Enzyme Research >Primer-Like Inhibitors for DNA Repair Enzymes of the AML-HL60 and WERI-1A/Y79 Malignant Cells
【24h】

Primer-Like Inhibitors for DNA Repair Enzymes of the AML-HL60 and WERI-1A/Y79 Malignant Cells

机译:AML-HL60和WERI-1A / Y79恶性细胞DNA修复酶的类似引物的抑制剂

获取原文
       

摘要

A conventionally synthesized thio- and cyano-modified single-stranded poly(dNTP) sequences of different molecular sizes (20 n - 200 n ) and the same lengths routine poly(dNTP) and poly(NTP) species were obtained through the good services provided by the Russian Federal Bioorganic Products Group and by the ThermoFischer, Inc., and then tested for their impact on catalytic activities of β -like DNA polymerases from chromatin of HL-60, WERI-1A and Y-79 cells as well as for the affinity patterns i n DNApol β -poly(dNTP)/ (NTP) pairs, respectively. An essential link between the lengths of ultrashort (50 n - 100 n ) single-stranded poly(dNTP) sequences of different structures and their inhibitory effects towards the cancer-specific DNA polymerases β has been found. A possible significance of this phenomenon for both DNA repair suppression in tumors and a consequent anti-cancer activity of the DNA repair related short poly(dNTP) fragments has been for the first time emphasized with a respect to their pharmacophore revealing potential. Thus, this work presents an experimental attempt to upgrade a contemporary attitude towards the DNA derived products applied for anti-cancer agenda, par ticularly, for acute myeloid leukemia and retinoblastoma cell DNA repair machinery breakdown. In this study, tumor specific DNA polymerases β were found of being the targets for attack promoted with the primer-like sin gle-stranded DNA fragments followed by consequent cytostatic phenomena. A novel concept of the DNA related anti-cancer medicines is under discus sion.
机译:不同分子大小(20 n -200 n )的常规合成的硫基和氰基修饰的单链聚(dNTP)序列常规的poly(dNTP)和poly(NTP)种类是通过俄罗斯联邦生物有机产品集团和ThermoFischer,Inc.提供的优质服务获得的,然后测试了它们对 β催化活性的影响HL-60,WERI-1A和Y-79细胞染色质的类DNA聚合酶以及DNApol中的亲和力模式 β -poly(dNTP)/(NTP)对。不同结构的超短(50 n -100 n )单链poly(dNTP)序列的长度与它们对DNA的抑制作用之间的重要联系已发现癌症特异性DNA聚合酶 β。就其药效团揭示潜力而言,首次强调了这种现象对于肿瘤中DNA修复抑制以及DNA修复相关的短聚(dNTP)短片段的抗癌活性的可能意义。因此,这项工作提出了一种实验尝试,旨在提高当代人们对用于抗癌议程的DNA衍生产品的态度,尤其是对急性髓细胞性白血病和成视网膜细胞瘤细胞DNA修复机制的破坏。在这项研究中,发现肿瘤特异性DNA聚合酶 β是引物样单链DNA片段促进的攻击靶标,随后发生了细胞抑制现象。目前正在讨论与DNA有关的抗癌药物的新概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号